Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

panitumumab

View Patient Information
A human IgG2kappa monoclonal antibody specific for the epidermal growth factor receptor (EGFR). Monoclonal antibody E7.6.3 binds to the EGFR, blocking the binding of epidermal growth factor and transforming growth factor alpha to EGFR-expressing cancer cells and ultimately inhibiting EGFR-dependent cell activation and proliferation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:ABX-EGF monoclonal antibody
ABX-EGF, clone E7.6.3
human IgG2K monoclonal antibody
monoclonal antibody ABX-EGF
monoclonal antibody E7.6.3
US brand name:Vectibix
Abbreviation:ABX-EGF
MoAb ABX-EGF
MoAb E7.6.3
Code name:E7.6.3
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search